Artemisinin Background

Artemisinin is a sesquiterpene trioxane lactone originally derived from the sweet wormwood plant (Artemisia annua), a traditional Chinese herb [1][4].

The compound was discovered during the Chinese "Cultural Revolution" in the 1970s through a secret government operation called the 523 Project, initiated to help the Vietnamese government combat malaria [1][5].

Professor Youyou Tu played a critical role in the discovery, searching through over 2000 herbal recipes and identifying Artemisia annua as a potential antimalarial treatment [1].

The discovery was groundbreaking, leading to a Nobel Prize and revolutionizing malaria treatment worldwide [5].

Artemisinin Systemic Applications

Artemisinin demonstrates remarkable versatility beyond its original antimalarial application, showing potential in treating various medical conditions [2][6].

The compound has been found to suppress neutrophil invasion, inhibit cytokine/chemokine secretion, and potentially treat conditions like systemic sepsis, ARDS, and Covid-19 [2].

It exhibits immunoregulatory effects on immune-mediated inflammatory diseases, including inflammatory bowel disease, psoriasis, rheumatoid arthritis, and multiple sclerosis [6].

Recent research suggests potential applications in autoimmune diseases and allograft rejection management [6].

Artemisinin for Brain and Cognition

Artemisinin has shown significant potential in improving cognitive functions, particularly in Alzheimer's disease models [3][7].

Studies demonstrated that artemisinin reduced amyloid-beta deposition, decreased inflammation factors, and reduced neuronal cell death [3].

Research indicates it can improve learning and memory by stimulating the ERK/CREB signaling pathway and protecting neuronal cells against Aβ-induced impairment [3][7].

The compound has been observed to reduce excessive astrocyte activation and improve cognitive abilities in animal models [7].

Artemisinin for Eye and Vision

Artemisinin and its derivatives show promising potential in ocular disease treatment [4][8].

Research has demonstrated its effectiveness in targeting disorders like uveitis, retinoblastoma, and retinal neurodegenerative diseases [4].

A specific derivative, artesunate, has been found to inhibit corneal neovascularization by inducing apoptosis in vascular endothelial cells [8].

Studies suggest artemisinins could be a promising therapeutic option for retinal vascular diseases in the future [4].

Relevant quotes:

"Artemisinin is a family of sesquiterpene trioxane lactone originally derived from the sweet wormwood plant" [4]

Relevant NCBI article quotes:

"Artemisinin and its derivatives (ARTs) have been shown to impact immune cells via different cellular and molecular mechanisms" [6]

Functions supported or stimulated:

1. Antimalarial activity

2. Immunoregulation

3. Neuroprotection

4. Anti-inflammatory response

5. Apoptosis induction

Related benefits:

1. Malaria treatment

2. Potential cancer therapy

3. Cognitive function improvement

4. Ocular disease management

5. Immune system modulation

Source Information:

Botanical name: Artemisia annua

Common names:

1. Sweet wormwood

2. Qinghao

3. Annual wormwood

Citations:

[1] https://pmc.ncbi.nlm.nih.gov/articles/PMC4966551/

[2] https://www.nature.com/articles/s41598-022-15214-6

[3] https://pmc.ncbi.nlm.nih.gov/articles/PMC7390534/

[4] https://pubmed.ncbi.nlm.nih.gov/31741871/

[5] https://pmc.ncbi.nlm.nih.gov/articles/PMC3414217/

[6] https://pmc.ncbi.nlm.nih.gov/articles/PMC8458561/

[7] https://www.mdpi.com/1422-0067/23/11/6354

[8] https://iovs.arvojournals.org/article.aspx?articleid=2189410

[9] https://www.parasite-journal.org/articles/parasite/full_html/2011/03/parasite2011183p215/parasite2011183p215.html

[10] https://pubmed.ncbi.nlm.nih.gov/39524446/

[11] https://journals.lww.com/md-journal/fulltext/2019/06210/intervention_of_artemisinin_in_macular_edema.23.aspx